Company Performance Metrics
- Gregory Meyers: COOPast Role: AIBioTech, Vice President, DNA Services
- Thomas Reynolds: President and Co-FounderPast Role: AIBioTech, Executive Vice President/Co-Founder
NEXT Molecular Analytics is a comprehensive contract research organization which provides integrated research and development sciences and clinical testing services to physicians and life science investigators in biotechnology and pharmaceutical companies, academic institutions, and in several different government agencies.
NEXT Molecular
Analytics is focused in (1) clinical testing using molecular and biochemical techniques; (2) molecular genetics of pharmacogenomics and cancer; (3) contract research in drug discovery and development with private sector customers; and (4) laboratory support of human clinical trials. They function as an extension of your own laboratory in helping you to bring their products from discovery to market. Their laboratories are certified under the Clinical Laboratory Improvement Amendments (CLIA) act and their contract research services are offered individually or can be integrated to support product development from discovery to market with full regulatory support under FDA GLP Guidelines 21 CFR 58.